Works by Kimmeskamp-Kirschbaum, Nina

Results: 10

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 6, p. 488, doi. 10.1002/cpdd.263

By:

Heinig, Roland;
Kimmeskamp‐Kirschbaum, Nina;
Halabi, Atef;
Lentini, Silvia

Publication type:

Article

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

Published in:

European Heart Journal, 2016, v. 37, n. 27, p. 2105, doi. 10.1093/eurheartj/ehw132

By:

Filippatos, Gerasimos;
Anker, Stefan D.;
BÃhm, Michael;
Gheorghiade, Mihai;
KÃber, Lars;
Krum, Henry;
Maggioni, Aldo P.;
Ponikowski, Piotr;
Voors, Adriaan A.;
Zannad, Faiez;
So-Young Kim;
Nowack, Christina;
Palombo, Giovanni;
Kolkhof, Peter;
Kimmeskamp-Kirschbaum, Nina;
Pieper, Alexander;
Pitt, Bertram

Publication type:

Article

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77111-4

By:

Fudim, Marat;
Khan, Muhammad Shahzeb;
Linz, Dominik;
Lindenfeld, JoAnn;
MacRae, Calum;
Kimmeskamp-Kirschbaum, Nina;
Meyer, Michaela;
Mondritzki, Thomas;
Tinel, Hanna;
Dinh, Wilfried;
Mentz, Robert J.

Publication type:

Article

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

Published in:

2015

By:

Bakris, George L;
Agarwal, Rajiv;
Chan, Juliana C;
Cooper, Mark E;
Gansevoort, Ron T;
Haller, Hermann;
Remuzzi, Giuseppe;
Rossing, Peter;
Schmieder, Roland E;
Nowack, Christina;
Kolkhof, Peter;
Joseph, Amer;
Pieper, Alexander;
Kimmeskamp-Kirschbaum, Nina;
Ruilope, Luis M;
Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group

Publication type:

journal article

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy.

Published in:

JAMA: Journal of the American Medical Association, 2015, v. 314, n. 9, p. 884, doi. 10.1001/jama.2015.10081

By:

Bakris, George L.;
Agarwal, Rajiv;
Chan, Juliana C.;
Cooper, Mark E.;
Gansevoort, Ron T.;
Haller, Hermann;
Remuzzi, Giuseppe;
Rossing, Peter;
Schmieder, Roland E.;
Nowack, Christina;
Kolkhof, Peter;
Joseph, Amer;
Pieper, Alexander;
Kimmeskamp-Kirschbaum, Nina;
Ruilope, Luis M.

Publication type:

Article

Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy.

Published in:

American Journal of Nephrology, 2015, v. 40, n. 6, p. 572, doi. 10.1159/000371497

By:

Ruilope, Luis M.;
Agarwal, Rajiv;
Chan, Juliana C.;
Cooper, Mark E.;
Gansevoort, Ron T.;
Haller, Hermann;
Remuzzi, Giuseppe;
Rossing, Peter;
Schmieder, Roland E.;
Nowack, Christina;
Ferreira, Anna C.;
Pieper, Alexander;
Kimmeskamp-Kirschbaum, Nina;
Bakris, George L.

Publication type:

Article

Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

Published in:

2014

By:

Ruilope, Luis M;
Agarwal, Rajiv;
Chan, Juliana C;
Cooper, Mark E;
Gansevoort, Ron T;
Haller, Hermann;
Remuzzi, Giuseppe;
Rossing, Peter;
Schmieder, Roland E;
Nowack, Christina;
Ferreira, Anna C;
Pieper, Alexander;
Kimmeskamp-Kirschbaum, Nina;
Bakris, George L

Publication type:

journal article

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.

Published in:

Fundamental & Clinical Pharmacology, 2016, v. 30, n. 2, p. 172, doi. 10.1111/fcp.12170

By:

Lentini, Silvia;
Heinig, Roland;
Kimmeskamp‐Kirschbaum, Nina;
Wensing, Georg

Publication type:

Article

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

Published in:

2015

By:

Pitt, Bertram;
Anker, Stefan D;
Böhm, Michael;
Gheorghiade, Mihai;
Køber, Lars;
Krum, Henry;
Maggioni, Aldo P;
Ponikowski, Piotr;
Voors, Adriaan A;
Zannad, Faiez;
Nowack, Christina;
Kim, So-Young;
Pieper, Alexander;
Kimmeskamp-Kirschbaum, Nina;
Filippatos, Gerasimos

Publication type:

journal article

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

Published in:

European Journal of Heart Failure, 2015, v. 17, n. 2, p. 224, doi. 10.1002/ejhf.218

By:

Pitt, Bertram;
Anker, Stefan D.;
Böhm, Michael;
Gheorghiade, Mihai;
Køber, Lars;
Krum, Henry;
Maggioni, Aldo P.;
Ponikowski, Piotr;
Voors, Adriaan A.;
Zannad, Faiez;
Nowack, Christina;
Kim, So‐Young;
Pieper, Alexander;
Kimmeskamp‐Kirschbaum, Nina;
Filippatos, Gerasimos

Publication type:

Article